1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Corporate Giving in Latin America & the Caribbean - HIV-AIDS & Liver Disease is sponsored by Gilead Sciences. Gilead Sciences is committed to ending the HIV epidemic in Latin America and the Caribbean, supporting organizations working to help individuals learn their HIV status and get the care they need.
They also fund local groups looking to meet the unique needs of the region, including increasing awareness and understanding of HIV incidence and treatment methods, facilitating medicine provision and local provider expertise, supporting linkage to care programs, and identifying and fostering prevention programs for at-risk individuals, including via pre-exposure prophylaxis (PrEP).
In the area of Liver Disease, Gilead supports projects to increase awareness of risk factors, improve diagnostics, and build medical specialization in hepatitis B (HBV) and HCV.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Organizations working in Latin America and the Caribbean that address HIV and liver diseases. Confirm the full requirements in the official notice before applying.
Corporate Giving in Latin America & the Caribbean - HIV-AIDS & Liver Disease is funded by Gilead Sciences. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleSchmidt Sciences opened a 'Scaling AI Safety for a Multi-Agent World' program with awards up to $1 million and an August 8, 2026 deadline. Against a backdrop of federal research slowdowns, here is why private science philanthropy matters more than ever, how these funders differ from federal agencies, and how researchers should approach them.
Read articleNSF's Arctic Research Opportunities solicitation funds roughly 75 awards a year — up to $50 million — across six program areas from natural sciences to social sciences to the Arctic Observing Network. The July 15, 2026 target date is not a hard deadline, and understanding that distinction is the first strategic decision an Arctic researcher makes. Here is how the six doors differ and how to choose the right one.
Read article